➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Colorcon
Baxter
Mallinckrodt
Merck

Last Updated: August 3, 2021

DrugPatentWatch Database Preview

GLYNASE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Glynase patents expire, and what generic alternatives are available?

Glynase is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in GLYNASE is glyburide. There are twenty drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the glyburide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Glynase

A generic version of GLYNASE was approved as glyburide by TEVA on August 29th, 1995.

  Try it Free

Drug patent expirations by year for GLYNASE
Drug Prices for GLYNASE

See drug prices for GLYNASE

Recent Clinical Trials for GLYNASE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Medical College of WisconsinPhase 4
TakedaPhase 4
TakedaPhase 3

See all GLYNASE clinical trials

Pharmacology for GLYNASE
Drug ClassSulfonylurea
Paragraph IV (Patent) Challenges for GLYNASE
Tradename Dosage Ingredient NDA Submissiondate
GLYNASE TABLET;ORAL glyburide 020051

US Patents and Regulatory Information for GLYNASE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer GLYNASE glyburide TABLET;ORAL 020051-001 Mar 4, 1992 AB RX Yes No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Pfizer GLYNASE glyburide TABLET;ORAL 020051-004 Sep 24, 1993 AB RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Pfizer GLYNASE glyburide TABLET;ORAL 020051-002 Mar 4, 1992 AB RX Yes No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Pfizer GLYNASE glyburide TABLET;ORAL 020051-003 Sep 24, 1993 DISCN Yes No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for GLYNASE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer GLYNASE glyburide TABLET;ORAL 020051-001 Mar 4, 1992 ⤷  Try it Free ⤷  Try it Free
Pfizer GLYNASE glyburide TABLET;ORAL 020051-002 Mar 4, 1992 ⤷  Try it Free ⤷  Try it Free
Pfizer GLYNASE glyburide TABLET;ORAL 020051-002 Mar 4, 1992 ⤷  Try it Free ⤷  Try it Free
Pfizer GLYNASE glyburide TABLET;ORAL 020051-001 Mar 4, 1992 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Colorcon
Baxter
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.